You just read:

Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients

News provided by

Valeant Pharmaceuticals International, Inc.

Feb 21, 2017, 07:30 ET